Characterization of binding of human fibrinogen to the surface of germ-tubes and mycelium of candida albicans.
The binding of human fibrinogen to germ-tubes and mycelium of Candida albicans, forms usually found in infected tissues, was studied in vitro by an immunofluorescence assay. Binding was quantified by using 125I-labelled fibrinogen. The degree of binding differed according to the morphological form of the fungus. Binding relative to that of the yeast form was greater for mycelium (12-fold) than for germ-tube (7.7-fold). Pretreatment of yeasts with fragments D and E (terminal degradation products of fibrinogen) before fibrinogen binding showed that fragment D possessed a higher affinity for C. albicans than fragment E. Binding of fibrinogen was diminished when C. albicans was pretreated with 2-mercaptoethanol alone or in combination with pronase, or pretreated with alpha-mannosidase or trypsin. Binding was not decreased by pretreatment with pronase alone or chitinase. Inhibition experiments using C. albicans dialysed culture filtrate, C. albicans mannan, chitin, sugars or amino sugars were done by preabsorbing the fibrinogen with each of the above mentioned compounds. C. albicans dialysed culture filtrate inhibited the binding more strongly than C. albicans mannan. However, fibrinogen binding to C. albicans was not significantly reduced by mannose, several other sugars or chitin. These studies demonstrate the existence of a fibrinogen-binding factor (FBF) strongly associated with the surface of germ-tube and filamentous forms of C. albicans, and indicate a possible role for FBF in the pathogenicity of C. albicans.
Bouali
A
A
Laboratoire d'Immunologie-Parasitologie-Mycologie, UFR des Sciences, Médicales et Pharmaceutiques, Angers, France.
Robert
R
R
Tronchin
G
G
Senet
J M
JM
D002176:Candida albicans / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism*; D002688:Chitinases / Q000494:pharmacology; D005340:Fibrinogen / Q000378:metabolism*; D005455:Fluorescent Antibody Technique; D006801:Humans; D008361:Mannosidases / Q000494:pharmacology; D008623:Mercaptoethanol / Q000494:pharmacology; D011402:Pronase / Q000494:pharmacology; D014357:Trypsin / Q000494:pharmacology
D008623:Mercaptoethanol; D005340:Fibrinogen; D008361:Mannosidases; D002688:Chitinases; D014357:Trypsin; D011402:Pronase